It is just poor writing. When you re-read, you'll see the author attempts to define two products, the unidentified antibiotic at $2B/yr and Lipitor which actually reached $14B/yr before going off patent.
33 posted on 03/08/2015 12:17:26 PM PDT by Zuben Elgenubi
(NOPe to GOPe)